[{"Assets_0_FY_USD":43529000000.0,"CommonStockSharesOutstanding_0_FY_shares":347821606.0,"EarningsPerShareBasic_1_FY_USD":-1.47,"EarningsPerShareBasic_4_FY_USD":-6.94,"EarningsPerShareDiluted_1_FY_USD":-1.47,"EarningsPerShareDiluted_4_FY_USD":-6.94,"NetCashProvidedByUsedInOperatingActivities_1_FY_USD":513000000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":2087000000.0,"StockholdersEquity_0_FY_USD":3152000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":347300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":347300000.0,"Ticker":"BHC","CIK":"885590","name":"VALEANT PHARMACEUTICALS INTERNATIONAL, INC.","OfficialName":"Bausch Health Companies Inc. Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7962573421.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NYSE","SP500":"nan","filed":"20170301"}]